Bausch + Lomb Corp. and Alfa Instruments today announced that the companies have entered into an exclusive submission agreement under which Bausch + Lomb will distribute and commercialize Alfa Instruments’ line of surgical intraocular dyes, Vitreocare, globally with the exception of  Italy, where Alfa Instruments is based.

According to the companies, the particular agreement expands and enhances Bausch + Lomb’s medical portfolio offering with Alfa Instruments’ differentiated intraocular chemical dyes, which possess been proven safe and effective in the European Union (EU).

“The addition associated with these clinically proven intraocular dyes to our already comprehensive surgical portfolio will help surgeons enhance the visibility of targeted eye tissues, as well as identify transparent layers of the eye during vitreoretinal, corneal and cataract surgery, “1-6 Joe Gordon, president, Global Consumer, Vision Care plus Surgical, Bausch + Lomb., said in the news release. “Our exclusive collaboration with Alfa Devices demonstrates our commitment to providing eye care professionals along with innovative products that are designed to help them achieve the particular best possible surgical outcomes for their patients. ”

Under the agreement, Bausch + Lomb will assume responsibility for all distribution and commercial activities of Vitreocare intraocular dyes, which includes:

  • Vitreo Lutein for vitreous staining
  • Single Lutein Blue for internal limiting membrane (ILM) staining
  • Double Lutein Blue with regard to ILM plus epiretinal membrane layer (ERM) discoloration
  • Phaco Lutein for anterior capsule staining
  • Trypan Glowing blue for anterior capsule discoloration

The companies pointed out that a common threat of the Vitreocare intraocular dyes is lutein, a natural blue light filter. Research has shown that lutein is a safe and effective dye agent, and its antioxidant properties can further protect the retina throughout eye surgery. 1-6

Moreover, Single Lutein Blue and Double Lutein Blue are usually formulated with the new high purity (> 99%) molecule Pure Benzyl-Brilliant Azure (PBB). PBB has been specifically designed within order in order to improve ILM binding affinity and to avoid diffusion in to retinal levels, in order to avoid potential cytotoxicity on off-target cells. 7

“We  are honored and delighted to collaborate with Bausch + Lomb,   one of the particular best known and most respected eye care companies in the world, because it will certainly expand access of our intraocular chemical dyes through Bausch + Lomb’s broad distribution network, ” Fabio David, CEO, Alfa Instruments, said within the news release. “We look forward to working together to assist improve the vision needs associated with patients undergoing vitreoretinal, cataract or corneal surgery. ”

Alfa Instruments’ surgical dyes are currently CE marked plus sold in the EU, the  United Kingdom, and  Switzerland. Bausch + Lomb expects to begin the particular distribution of the intraocular dyes in almost all EU countries, using the exclusion of  Italia, during the first half of 2023. Bausch + Lomb and Alfa Instruments are also in the process of exploring regulatory requirements and approvals from the surgical dyes within other markets.

Leave a Reply

Your email address will not be published.